No Data
No Data
RemeGen Co. Ltd. to Strengthen Leadership With New Director
RemeGen Co. Ltd. Announces 2025 Extraordinary Meeting
REMEGEN (09995.HK): Huang Guobin has been nominated as an independent non-executive Director candidate.
Gelonghui, December 23丨REMEGEN (09995.HK) announced that at the Board of Directors meeting to be held on December 23, 2024, Huang Guobin has been nominated as a candidate for the company's independent non-executive director.
RemeGen Co., Ltd. Announces H Shares Register Closure
Express News | RemeGen Co Ltd: Safety Profile in Phase III Study of Disitamab Vedotin Was Consistent With Past Disitamab Vedotin Use Experience
Express News | RemeGen Co Ltd: Disitamab Vedotin Significantly Improved Progression-Free Survival Versus Lapatinib Plus Capecitabine
No Data